RS
Ravi Subbanna Chandakavadi
About Ravi Subbanna Chandakavadi
Data last updated:
Ravi Subbanna Chandakavadi is a Director at Snig Pharma Private Limited (since 2017). The company operates in Pharma. Snig Pharma Private Limited reported revenue of ₹6.94 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Nov 2017 | 2015 | ₹6.94 Cr (FY 2025) | Active |
Board colleagues of Ravi Subbanna Chandakavadi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Davanagere Ravindra Santhosh | 11596646 | Snig Pharma Private Limited | Additional Director |
| Marilinge Gowda Vivekananda | 07794342 | Snig Pharma Private Limited | Director |
| Poornima Patil | 07160195 | Snig Pharma Private Limited | Director |
| Raghukumar Jogad | 07985292 | Snig Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Subbanna Chandakavadi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Subbanna Chandakavadi
Ravi Subbanna Chandakavadi currently holds 1 directorship: Snig Pharma Private Limited (Director, since 25 Nov 2017, revenue ₹6.94 Cr (FY 2025)).
Ravi Subbanna Chandakavadi was first appointed on 25 Nov 2017 as Director at Snig Pharma Private Limited.
The current boards of Ravi Subbanna Chandakavadi's companies include Davanagere Ravindra Santhosh (Snig Pharma Private Limited), Marilinge Gowda Vivekananda (Snig Pharma Private Limited), Poornima Patil (Snig Pharma Private Limited), Raghukumar Jogad (Snig Pharma Private Limited).